186 related articles for article (PubMed ID: 24559085)
1. Podocin and beta dystroglycan expression to study podocyte-podocyte and basement membrane matrix connections in adult protienuric states.
Shankar PB; Nada R; Joshi K; Kumar A; Rayat CS; Sakhuja V
Diagn Pathol; 2014 Feb; 9():40. PubMed ID: 24559085
[TBL] [Abstract][Full Text] [Related]
2. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
3. Dystroglycan in the diagnosis of FSGS.
Giannico G; Yang H; Neilson EG; Fogo AB
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1747-53. PubMed ID: 19808230
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases.
Schmid H; Henger A; Cohen CD; Frach K; Gröne HJ; Schlöndorff D; Kretzler M
J Am Soc Nephrol; 2003 Nov; 14(11):2958-66. PubMed ID: 14569107
[TBL] [Abstract][Full Text] [Related]
5. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
6. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
[TBL] [Abstract][Full Text] [Related]
7. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
8. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
Kim EY; Roshanravan H; Dryer SE
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718
[TBL] [Abstract][Full Text] [Related]
9. Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2007; 27(6):710-5. PubMed ID: 18336100
[TBL] [Abstract][Full Text] [Related]
10. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
Srivastava T; Garola RE; Singh HK
Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
[TBL] [Abstract][Full Text] [Related]
11. Inducible ATF3-NFAT axis aggravates podocyte injury.
Zhang H; Liang S; Du Y; Li R; He C; Wang W; Liu S; Ye Z; Liang X; Shi W; Zhang B
J Mol Med (Berl); 2018 Jan; 96(1):53-64. PubMed ID: 29038896
[TBL] [Abstract][Full Text] [Related]
12. In situ evaluation of podocin in normal and glomerular diseases.
Horinouchi I; Nakazato H; Kawano T; Iyama K; Furuse A; Arizono K; Machida J; Sakamoto T; Endo F; Hattori S
Kidney Int; 2003 Dec; 64(6):2092-9. PubMed ID: 14633131
[TBL] [Abstract][Full Text] [Related]
13. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy.
Lai KN; Leung JC; Chan LY; Saleem MA; Mathieson PW; Tam KY; Xiao J; Lai FM; Tang SC
Nephrol Dial Transplant; 2009 Jan; 24(1):62-72. PubMed ID: 18685143
[TBL] [Abstract][Full Text] [Related]
14. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
15. Multi-glycoside of Tripterygium wilfordii Hook. f. reduces proteinuria through improving podocyte slit diaphragm dysfunction in anti-Thy1.1 glomerulonephritis.
Wan YG; Sun W; Zhen YJ; Che XY; Pu HP; Wang Y; Li M; Ruan JG; Yan QJ
J Ethnopharmacol; 2011 Jun; 136(2):322-33. PubMed ID: 21570456
[TBL] [Abstract][Full Text] [Related]
16. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
Zeng C; Fan Y; Wu J; Shi S; Chen Z; Zhong Y; Zhang C; Zen K; Liu Z
J Pathol; 2014 Oct; 234(2):203-13. PubMed ID: 24870816
[TBL] [Abstract][Full Text] [Related]
17. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
18. Development of podocyte injuries in Osborne-Mendel rats is accompanied by reduced expression of podocyte proteins.
Yasuno K; Araki S; Sakashita H; Kobayashi R; Baba T; Kawakami H; Kamiie J; Ogihara K; Shirota K
J Comp Pathol; 2013; 149(2-3):280-90. PubMed ID: 23582971
[TBL] [Abstract][Full Text] [Related]
19. CD73 Overexpression in Podocytes: A Novel Marker of Podocyte Injury in Human Kidney Disease.
Popovic ZV; Bestvater F; Krunic D; Krämer BK; Bergner R; Löffler C; Hocher B; Marx A; Porubsky S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299260
[TBL] [Abstract][Full Text] [Related]
20. Temporal and spatial expression of podocyte-associated molecules are accompanied by proteinuria in IgA nephropathy rat model.
Lu H; Chen LL; Jiang XY; Mo Y; Ling YH; Sun LZ
Physiol Res; 2013; 62(1):35-45. PubMed ID: 23173680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]